FOXI1 and Hodgkins lymphoma: Nevertheless, the variant is enriched in individuals diagnosed with HL and EVA (3 in 56 alleles in the study cohort versus 165 in 26.590 alleles of the in-house WES cohort, p value 0.0004), and we consider the c.677C > T FOXI1 variant as an interesting candidate for functional validation.